PRESS RELEASE Casey-Drew Williams 2/10/25 PRESS RELEASE Casey-Drew Williams 2/10/25 The University of Pittsburgh Has Joined the NGD Consortium Read More PRESS RELEASE Casey-Drew Williams 1/7/25 PRESS RELEASE Casey-Drew Williams 1/7/25 Next Gen Diagnostics and Sheba Medical Center Announce Agreement for NGD to Sequence and Analyze Unique Collection of Highly Resistant Bacterial Infections Read More NEWS STORY Casey-Drew Williams 12/13/24 NEWS STORY Casey-Drew Williams 12/13/24 Next Gen Diagnostics Developing Automated NGS Workflow for Outbreak Detection, Antibiotic Resistance Dx Read More PRESS RELEASE Casey-Drew Williams 11/19/24 PRESS RELEASE Casey-Drew Williams 11/19/24 Next Gen Diagnostics Announces New York State Department of Health’s Wadsworth Center Has Joined the NGD Cefiderocol Data Consortium for the Sequencing-Based Determination of Cefiderocol Resistance Read More PRESS RELEASE Casey-Drew Williams 10/7/24 PRESS RELEASE Casey-Drew Williams 10/7/24 Next Gen Diagnostics Announces Agreement to Develop Sequence-Based Susceptibility Determination of cefiderocol Read More PRESS RELEASE Casey-Drew Williams 6/11/24 PRESS RELEASE Casey-Drew Williams 6/11/24 Next Gen Diagnostics Announces Opening of a US Sequencing and Bioinformatics Laboratory in Cambridge, Massachusetts Read More PRESS RELEASE Casey-Drew Williams 6/10/24 PRESS RELEASE Casey-Drew Williams 6/10/24 Next Gen Diagnostics CEO Paul Rhodes Announces that Dr. Linoj Samuel has Joined NGD’s Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 5/20/24 PRESS RELEASE Casey-Drew Williams 5/20/24 Next Gen Diagnostics and Vanderbilt Report the Use of Whole Genome Sequencing to Detect Transmission of Infection in a Neonatal Intensive Care Unit Read More PRESS RELEASE Casey-Drew Williams 2/26/24 PRESS RELEASE Casey-Drew Williams 2/26/24 Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing Read More PRESS RELEASE Casey-Drew Williams 11/2/23 PRESS RELEASE Casey-Drew Williams 11/2/23 Next Gen Diagnostics CEO Paul Rhodes Announces that Patricia Simner has Joined NGD’s Scientific Advisory Board Read More PRESS RELEASE Casey-Drew Williams 10/9/23 PRESS RELEASE Casey-Drew Williams 10/9/23 Next Gen Diagnostics CEO Paul Rhodes Announces Plan to for NGD’s subsidiary, Next Gen Diagnostics, Israel, Ltd., to Open Lab at Sheba Hospital in Tel Aviv Read More PRESS RELEASE Casey-Drew Williams 3/6/23 PRESS RELEASE Casey-Drew Williams 3/6/23 Next Gen Diagnostics CEO Paul Rhodes Announces Formation of UK Subsidiary, Next Gen Diagnostics UK, Ltd. Read More Older Posts
PRESS RELEASE Casey-Drew Williams 2/10/25 PRESS RELEASE Casey-Drew Williams 2/10/25 The University of Pittsburgh Has Joined the NGD Consortium Read More
PRESS RELEASE Casey-Drew Williams 1/7/25 PRESS RELEASE Casey-Drew Williams 1/7/25 Next Gen Diagnostics and Sheba Medical Center Announce Agreement for NGD to Sequence and Analyze Unique Collection of Highly Resistant Bacterial Infections Read More
NEWS STORY Casey-Drew Williams 12/13/24 NEWS STORY Casey-Drew Williams 12/13/24 Next Gen Diagnostics Developing Automated NGS Workflow for Outbreak Detection, Antibiotic Resistance Dx Read More
PRESS RELEASE Casey-Drew Williams 11/19/24 PRESS RELEASE Casey-Drew Williams 11/19/24 Next Gen Diagnostics Announces New York State Department of Health’s Wadsworth Center Has Joined the NGD Cefiderocol Data Consortium for the Sequencing-Based Determination of Cefiderocol Resistance Read More
PRESS RELEASE Casey-Drew Williams 10/7/24 PRESS RELEASE Casey-Drew Williams 10/7/24 Next Gen Diagnostics Announces Agreement to Develop Sequence-Based Susceptibility Determination of cefiderocol Read More
PRESS RELEASE Casey-Drew Williams 6/11/24 PRESS RELEASE Casey-Drew Williams 6/11/24 Next Gen Diagnostics Announces Opening of a US Sequencing and Bioinformatics Laboratory in Cambridge, Massachusetts Read More
PRESS RELEASE Casey-Drew Williams 6/10/24 PRESS RELEASE Casey-Drew Williams 6/10/24 Next Gen Diagnostics CEO Paul Rhodes Announces that Dr. Linoj Samuel has Joined NGD’s Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 5/20/24 PRESS RELEASE Casey-Drew Williams 5/20/24 Next Gen Diagnostics and Vanderbilt Report the Use of Whole Genome Sequencing to Detect Transmission of Infection in a Neonatal Intensive Care Unit Read More
PRESS RELEASE Casey-Drew Williams 2/26/24 PRESS RELEASE Casey-Drew Williams 2/26/24 Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing Read More
PRESS RELEASE Casey-Drew Williams 11/2/23 PRESS RELEASE Casey-Drew Williams 11/2/23 Next Gen Diagnostics CEO Paul Rhodes Announces that Patricia Simner has Joined NGD’s Scientific Advisory Board Read More
PRESS RELEASE Casey-Drew Williams 10/9/23 PRESS RELEASE Casey-Drew Williams 10/9/23 Next Gen Diagnostics CEO Paul Rhodes Announces Plan to for NGD’s subsidiary, Next Gen Diagnostics, Israel, Ltd., to Open Lab at Sheba Hospital in Tel Aviv Read More
PRESS RELEASE Casey-Drew Williams 3/6/23 PRESS RELEASE Casey-Drew Williams 3/6/23 Next Gen Diagnostics CEO Paul Rhodes Announces Formation of UK Subsidiary, Next Gen Diagnostics UK, Ltd. Read More